Speciality
Spotlight

 




 


Respiratory – Pulmonary – Asthma


 

 





Tuberculosis

    

  • ST Cole, R Brosch, J Parkhill, et al (Wellcome Trust Genome Campus, Hinxton, UK; Institut Pasteur, Paris; NIH, Hamilton, Mont; et al) 


    Deciphering the Biology of Mycobacterium tuberculosis from the complete Genome Sequence. 


    Nature 393:537-544, 1998

       


    The pattern of dormancy and reactivation observed in the tubercle bacillus plays a key role in the chronic nature of tuberculosis. This pattern is believed to be genetically programmed. The most widely studied strain of M.tuberculosis is the H37Rv strain.

      


    Even after years of study, the molecular basis of virulence of the tubercle bacillus remains unclear.


      

  • A
    Pabloz-Mendez, for the WHO-International Union Against tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance WHO, Geneva; Columbia Univ, New York; International Union against Tuberculosis and Lung Disease, Paris; et al). 


    Global Surveillance for Antituberculosis-Drug Resistance,
    1994-1997. 

    N Engl J Med 338:1641-1649, 1998.

      


    The report includes 1994-1997 data on multidrug resistance, defined as resistance to at least isoniazid and rifampin.

      


    About one third of all tuberculosis cases worldwide were found in India.


      


 



 

 

Speciality Spotlight

 

 

Tuberculosis
    

  • ST Cole, R Brosch, J Parkhill, et al (Wellcome Trust Genome Campus, Hinxton, UK; Institut Pasteur, Paris; NIH, Hamilton, Mont; et al) 
    Deciphering the Biology of Mycobacterium tuberculosis from the complete Genome Sequence. 
    Nature 393:537-544, 1998
       
    The pattern of dormancy and reactivation observed in the tubercle bacillus plays a key role in the chronic nature of tuberculosis. This pattern is believed to be genetically programmed. The most widely studied strain of M.tuberculosis is the H37Rv strain.
      
    Even after years of study, the molecular basis of virulence of the tubercle bacillus remains unclear.

      

  • A Pabloz-Mendez, for the WHO-International Union Against tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance WHO, Geneva; Columbia Univ, New York; International Union against Tuberculosis and Lung Disease, Paris; et al). 
    Global Surveillance for Antituberculosis-Drug Resistance, 1994-1997. 
    N Engl J Med 338:1641-1649, 1998.
      
    The report includes 1994-1997 data on multidrug resistance, defined as resistance to at least isoniazid and rifampin.
      
    About one third of all tuberculosis cases worldwide were found in India.

      

 

 

By |2022-07-20T16:41:47+00:00July 20, 2022|Uncategorized|Comments Off on Tuberculosis

About the Author: